Trial Profile
Intravenous Prostaglandin E1 Treatment in Outpatients With Intermittent Claudication.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Alprostadil (Primary) ; Pentoxifylline
- Indications Embolism and thrombosis; Intermittent claudication; Peripheral arterial occlusive disorders
- Focus Registrational; Therapeutic Use
- Sponsors Schwarz Pharma AG; UCB
- 26 May 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 26 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Dec 2010 New trial record